Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: Nivolumab
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Kompass Onkologie
Kompass Onkol (2019) 6 (2): 104–105.
Published Online: 27 May 2019
... to in the content or advertisements. Atezolizumab Immune checkpoint blockade Nivolumab Non-small-cell lung cancer Patient selection Pembrolizumab Literatur 1. Malhotra J, Jabbour SK, Aisner J: Current state of immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res...
Journal Articles
Subject Area:
Oncology
Journal:
Kompass Onkologie
Kompass Onkol (2018) 5 (2): 103–104.
Published Online: 12 April 2018
... of the pancreas using nivolumab as a treatment of last resort. We noted a favorable and durable response suggesting that this may be superior to all currently available options for palliative treatment in a similar scenario. Entscheidend für das palliativmedizinische Behandlungskonzept ist neben anderen...
Journal Articles
Subject Area:
Oncology
Journal:
Kompass Onkologie
Kompass Onkol (2017) 4 (1): 50–53.
Published Online: 24 March 2017
...Amruth R. Palla; Devin Kennedy; Hossain Mosharraf; Donald Doll Zusammenfassung In letzter Zeit ist das Instrumentarium zur Bekämpfung verschiedener maligner Erkrankungen maßgeblich um mehrere Immuntherapeutika erweitert worden - von PD-1-Inhibitoren (Nivolumab, Pembrolizumab) über PD-L1-Inhibitoren...
